Guardant Health Stock Investor Sentiment

GH Stock  USD 18.10  0.76  4.38%   
Under 59% of Guardant Health's investor base is looking to short. The analysis of overall sentiment of trading Guardant Health stock suggests that many investors are alarmed at this time. Guardant Health's investor sentiment overview provides quick insight into current market opportunities from investing in Guardant Health. The current market sentiment, together with Guardant Health's historical and current headlines, can help investors time the market. In addition, many technical investors use Guardant Health stock news signals to limit their universe of possible portfolio assets and to time the market correctly.

Panic Vs Confidence

41

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Guardant Health's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Guardant Health.
Guardant Health stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Guardant daily returns and investor perception about the current price of Guardant Health as well as its diversification or hedging effects on your existing portfolios.

Guardant Historical Sentiment

Although Guardant Health's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Guardant, such as negative comments on social media and news outlets, may cause fear in the market and push Guardant Health's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Guardant.
  

Guardant Health Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Guardant Health can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Guardant Health Historical Investor Sentiment

Investor biases related to Guardant Health's public news can be used to forecast risks associated with an investment in Guardant. The trend in average sentiment can be used to explain how an investor holding Guardant can time the market purely based on public headlines and social activities around Guardant Health. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Guardant Health's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Guardant Health and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Guardant Health news discussions. The higher the estimate score, the more favorable the investor's outlook on Guardant Health.

Guardant Health Maximum Pain Price across 2024-05-17 Option Contracts

Guardant Health's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Guardant Health close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Guardant Health's options.
a day ago at investing.com         
Guardant Health shares rated Buy, target set at 28
Investing News at Macroaxis
3 days ago at businesswire.com         
FDA Advisory Panel Review of Guardant Healths Shield Blood Test to Screen for Colorectal Cancer to B...
businesswire News
3 days ago at investing.com         
FDA to review Guardant Healths cancer screening test
Investing News at Macroaxis
3 days ago at businesswire.com         
FDA Advisory Panel Review of Guardant Healths Shield Blood Test to Screen for Colorectal Cancer to B...
businesswire News
six days ago at businesswire.com         
Guardant Health to Report First Quarter 2024 Financial Results on May 9, 2024
businesswire News
over a week ago at news.google.com         
Guardant Health Sets New 12-Month Low Following Analyst Downgrade - MarketBeat
Google News at Macroaxis
over a week ago at www.macroaxis.com         
Disposition of tradable shares by Potter Myrtle S of Guardant Health subject to Rule 16b-3
Macroaxis News
over two weeks ago at news.google.com         
Guardant Health Stock Price Up 4.9 percent - MarketBeat
Google News at Macroaxis
over two weeks ago at news.google.com         
Guggenheim Reiterates Neutral Rating for Guardant Health - MarketBeat
Google News at Macroaxis
over two weeks ago at www.macroaxis.com         
Disposition of tradable shares by Joyce Meghan V. of Guardant Health subject to Rule 16b-3
Macroaxis News
over two weeks ago at finbold.com         
The next Nvidia 3 stocks poised for massive growth in 2024
news
over two weeks ago at investing.com         
Guardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncolog...
Investing News at Macroaxis
over three weeks ago at investorplace.com         
Disposition of 1340 shares by Darya Chudova of Guardant Health subject to Rule 16b-3
sbwire news
over three weeks ago at news.google.com         
Disposition of 11461 shares by Helmy Eltoukhy of Guardant Health subject to Rule 16b-3
Google News at Macroaxis
over three weeks ago at simplywall.st         
Does Guardant Health Have A Healthy Balance Sheet?
Simply Wall St News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Guardant Health that are available to investors today. That information is available publicly through Guardant media outlets and privately through word of mouth or via Guardant internal channels. However, regardless of the origin, that massive amount of Guardant data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Guardant Health news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Guardant Health relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Guardant Health's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Guardant Health alpha.

Guardant Health Performance against NYSE Composite

 Price Growth (%)  
       Timeline  
1
Guardant Health Non-GAAP EPS of -0.64 beats by 0.11, revenue of 155.1M beats by 4.31M
02/22/2024
2
Acquisition by Krognes Steve E. of 154 shares of Guardant Health subject to Rule 16b-3
02/29/2024
3
Guardant Health Reaches New 12-Month Low at 18.18 - MarketBeat
03/14/2024
4
Disposition of 1233 shares by Michael Bell of Guardant Health subject to Rule 16b-3
03/15/2024
5
EDAN y GH Labs colabora para desarrollar dispositivos de ultrasonido habilitados para IA
03/18/2024
6
EDAN et GH Labs collaborent pour dvelopper des appareils ultrasons bass sur lIA
03/19/2024
7
Acquisition by Merrill Amelia of 158 shares of Guardant Health subject to Rule 16b-3
03/25/2024
8
Guardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual Meeting
04/03/2024
9
Disposition of tradable shares by Joyce Meghan V. of Guardant Health subject to Rule 16b-3
04/04/2024
10
Guggenheim Reiterates Neutral Rating for Guardant Health - MarketBeat
04/05/2024
11
Disposition of tradable shares by Potter Myrtle S of Guardant Health subject to Rule 16b-3
04/15/2024
12
Guardant Health Sets New 12-Month Low Following Analyst Downgrade - MarketBeat
04/16/2024
13
FDA Advisory Panel Review of Guardant Healths Shield Blood Test to Screen for Colorectal Cancer to Be Held on May 23
04/22/2024
When determining whether Guardant Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Guardant Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Guardant Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Guardant Health Stock:
Check out Guardant Health Hype Analysis, Guardant Health Correlation and Guardant Health Performance.
For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.
Note that the Guardant Health information on this page should be used as a complementary analysis to other Guardant Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Complementary Tools for Guardant Stock analysis

When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Is Guardant Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.28)
Revenue Per Share
5.036
Quarterly Revenue Growth
0.222
Return On Assets
(0.18)
Return On Equity
(4.38)
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.